Mateusz Opyrchal named inaugural Vera Bradley Foundation Scholar in Breast Cancer Discovery at IU

Kaklamani: The San Antonio Breast Cancer Symposium will focus on deescalating treatment while maintaining outcomes

The San Antonio Breast Cancer Symposium will focus on doing the same with less—less surgery, less radiation, while maintaining clinical outcomes. The symposium will take place Dec. 10-13 in San Antonio, TX.

A clinic at Fred Hutch addresses sexual health needs of patients with breast cancer
Data indicate low adherence to ASCO guideline

New data indicate that, professional guidelines notwithstanding, doctors rarely address concerns about sexual health when they treat women with cancer.

November 15, 2024

Vol.50 No.43

By Claire Marie Porter

In Brief

NCI renews IU Simon Comprehensive Cancer Center’s designation

NCI renewed the Comprehensive Cancer Center designation to the Indiana University Melvin and Bren Simon Comprehensive Cancer Center, awarding it a five-year, $14.2 million grant.

November 15, 2024

Vol.50 No.43

In Brief

Melissa Fishel named Myles Brand Scholar in Cancer Research at IU Simon

Melissa L. Fishel was named the Myles Brand Scholar in Cancer Research by Indiana University Melvin and Bren Simon Comprehensive Cancer Center. Fishel is a tumor cell biologist working toward new targets and treatments for pancreatic cancer.

November 15, 2024

Vol.50 No.43

In Brief

Fred Hutch, UW, and Seattle Children’s consortium researchers receive $1.7M from Breast Cancer Research Foundation

Six Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium scientists received $1.7M in grants from Breast Cancer Research Foundation to launch or continue studies aimed at improving outcomes in breast cancer.

November 15, 2024

Vol.50 No.43

Clinical Roundup

Preclinical data show anti-CD24 macrophage checkpoint inhibitor promotes phagocytosis and shrinks tumors

New preclinical data for PHST001, an anti-CD24 antibody drug candidate that is designed to block a key macrophage “don’t eat me” signal on cancer cells, were presented at the 39th Annual Meeting of the Society for Immunotherapy of Cancer. The meeting is taking place both virtually and at the George R. Brown Convention Center in...

November 08, 2024

Vol.50 No.42

Mateusz Opyrchal named inaugural Vera Bradley Foundation Scholar in Breast Cancer Discovery at IU

YOU MAY BE INTERESTED IN

Kaklamani: The San Antonio Breast Cancer Symposium will focus on deescalating treatment while maintaining outcomes

A clinic at Fred Hutch addresses sexual health needs of patients with breast cancer
Data indicate low adherence to ASCO guideline

NCI renews IU Simon Comprehensive Cancer Center’s designation

Melissa Fishel named Myles Brand Scholar in Cancer Research at IU Simon

Fred Hutch, UW, and Seattle Children’s consortium researchers receive $1.7M from Breast Cancer Research Foundation

Preclinical data show anti-CD24 macrophage checkpoint inhibitor promotes phagocytosis and shrinks tumors

Renew today!

Subscriber content

Never miss an issue!

Login

Mateusz Opyrchal named inaugural Vera Bradley Foundation Scholar in Breast Cancer Discovery at IU

YOU MAY BE INTERESTED IN

Kaklamani: The San Antonio Breast Cancer Symposium will focus on deescalating treatment while maintaining outcomes

A clinic at Fred Hutch addresses sexual health needs of patients with breast cancerData indicate low adherence to ASCO guideline

NCI renews IU Simon Comprehensive Cancer Center’s designation

Melissa Fishel named Myles Brand Scholar in Cancer Research at IU Simon

Fred Hutch, UW, and Seattle Children’s consortium researchers receive $1.7M from Breast Cancer Research Foundation

Preclinical data show anti-CD24 macrophage checkpoint inhibitor promotes phagocytosis and shrinks tumors

Never miss an issue!

Login

A clinic at Fred Hutch addresses sexual health needs of patients with breast cancer
Data indicate low adherence to ASCO guideline